About Regenerative Medicine China
A specialist international patient-access service built to make regenerative medicine pathways in China clearer, more verifiable and easier to navigate.
Patients need more than a list of clinics.
Regenerative medicine is a fast-moving field in which research, clinical development, limited clinical application and aggressive marketing can look similar online. International patients may also struggle to verify Chinese-language sources, hospital access and practical requirements.
Regenerative Medicine China was created to organise that uncertainty into a staged process: identify the condition, verify the route, prepare the records, obtain institutional review and coordinate the journey only when a credible pathway exists.
What we do — and what we do not do
We do
- Research treatment and clinical-access pathways
- Prepare international patient case summaries
- Coordinate hospital or specialist review
- Verify foreign-patient intake and practical requirements
- Separate medical fees from coordination services
- Support appointments, language, travel and follow-up
We do not
- Operate a hospital, clinic or laboratory
- Manufacture or administer cells
- Guarantee treatment eligibility or outcomes
- Sell clinical-trial participation
- Describe research activity as routine treatment
- Replace the patient’s treating physician
Part of a wider China medical-access platform.
Access China Med supports international patients seeking hospitals, specialists, diagnostics, surgery and treatment in China. My China Checkup focuses on preventive health checks. Regenerative Medicine China is the specialist vertical for regenerative medicine, cell therapy, verification and healthy aging.
This structure allows a patient to move to a conventional specialist pathway when regenerative treatment is not appropriate, rather than being forced into one product category.
Visit Access China MedClarity before conversion.
Condition first
We begin with diagnosis and records, not a treatment package.
Status visible
Clinical application, trial and research are labelled separately.
Hospital decides
Eligibility and medical plans belong to the institution.
Fees separated
Medical care and coordination are not hidden in one unexplained price.
Frequently asked questions
No. We are an independent international patient coordination service and a specialist service by Access China Med.
No. We are not a government portal or regulatory authority.
Commercial arrangements may vary by provider. Patients should receive clear information about our coordination fee, and hospital medical fees are kept separate.
We provide information and coordination. Medical advice, diagnosis, eligibility, treatment and consent are provided by qualified clinicians and institutions.
Regenerative medicine has unusually complex status, evidence and access questions. A specialist pathway helps patients avoid confusing research, marketing and real clinical access.
We will not present it as confirmed. We can explain the missing evidence or access information and, where appropriate, suggest another medical route.
Start with a confidential case summary
Tell us your diagnosis, current treatment and main goal. We will first check whether a credible pathway may justify formal hospital review.